BUY METHANDIENONE (DIANABOL) (10 MG/TAB. – 100 TABS)
MAIN PRODUCT DESCRIPTION
Product Overview & Pharmaceutical Specifications
Methandienone 10 mg (Dianabol) is described in the supplied information as an oral anabolic-androgenic steroid containing 10 mg of methandienone per tablet. The product is supplied as 100 uncoated tablets in one bottle.
Methandienone is a synthetic anabolic-androgenic steroid that acts through the androgen receptor. The supplied source associates its pharmacological activity with protein synthesis and nitrogen retention in muscle tissue.
Methandienone is also a 17-alpha-alkylated compound, a structural modification that allows oral administration by reducing hepatic breakdown. However, this modification is also associated with important liver-related safety considerations.
Product Specifications
Product: Methandienone 10
Common name: Dianabol
Active Ingredient: Methandienone
Strength: 10 mg/tablet
Pack Size: 100 tablets
Dosage Form: Uncoated tablet
Route: Oral
Drug Class: Anabolic-androgenic steroid
Molecular Formula: C20H28O2
Molecular Weight: 300.441 g/mol
CAS Number: 72-63-9
Market Status: Prescription
Company: Hilma Biocare
Pharmacological Classification
Methandienone belongs to the anabolic-androgenic steroid class. These compounds are synthetic derivatives of testosterone that can influence androgen-responsive tissues through the androgen receptor.
Activation of androgen receptors can affect gene expression and protein metabolism in various tissues, including skeletal muscle and reproductive organs.
The supplied source specifically associates methandienone with increased nitrogen retention and protein synthesis. These mechanisms form part of the pharmacology of anabolic steroids but should not be interpreted as a guarantee of increased strength or muscle mass.
Oral 17-Alpha-Alkylated Steroid
Methandienone contains a 17-alpha-alkyl modification that increases its suitability for oral administration by reducing hepatic metabolism.
This structural feature is pharmacologically important because it helps the compound remain available after oral administration. At the same time, 17-alpha-alkylated anabolic steroids have recognised associations with hepatic adverse effects.
The supplied information specifically identifies methandienone as hepatotoxic and recommends monitoring liver function.
Androgen-Receptor Activity
Methandienone acts directly through androgen receptors. These receptors are intracellular proteins involved in regulating androgen-sensitive genes.
Androgen receptor signalling is responsible for many physiological effects of testosterone and synthetic anabolic steroids. These include effects on muscle tissue, bone, reproductive organs, skin and other androgen-responsive systems.
Because methandienone influences androgen signalling throughout the body, its effects are not limited to skeletal muscle.
Protein Synthesis and Nitrogen Balance
The supplied source states that methandienone increases protein synthesis and nitrogen retention within muscle cells.
Protein synthesis is an essential process for tissue maintenance and growth, while nitrogen balance reflects the relationship between nitrogen intake and nitrogen loss.
Androgenic steroid activity can influence protein metabolism, but nutritional status, physical activity, endocrine function and other factors also affect nitrogen balance.
The product should therefore not be marketed as guaranteeing a specific amount of muscle growth or strength gain.
Clinical Context
The supplied information lists several clinical contexts for methandienone, including restoration of muscle tissue following traumatic injury, reduction of muscle catabolism in wasting syndromes and treatment of certain types of anaemia that do not respond to first-line therapy.
These are the indications stated in the supplied material. They have not been independently verified for this particular commercial presentation or for any specific European jurisdiction.
The product should therefore not be described as an officially authorised treatment for these conditions without appropriate regulatory documentation.
Aromatisation and Oestrogenic Activity
The supplied source states that methandienone is subject to aromatisation, producing oestrogenic metabolites.
This is relevant to the pharmacology of methandienone because conversion to oestrogen can contribute to oestrogen-related effects.
The supplied source mentions gynecomastia and fluid retention among possible adverse reactions. These effects should be considered when evaluating the pharmacological profile of the compound.
No recommendation to use an aromatase inhibitor or another medicine to counteract these effects has been added.
Pharmacokinetics
The supplied product information gives a reported half-life of approximately 4.5–6 hours and identifies the liver as an important site of methandienone metabolism.
Short half-life does not determine an appropriate human treatment schedule on its own. The pharmacokinetic profile of the finished product should be interpreted together with official prescribing information and clinical factors.
Hepatic Safety
Because methandienone is a 17-alpha-alkylated oral steroid, liver safety is an important consideration.
The supplied source reports potential:
Elevated liver enzymes
Cholestatic hepatitis
Jaundice
Altered liver-function tests
Rare hepatic lesions
The source recommends monitoring bilirubin, AST, ALT and alkaline phosphatase during treatment.
Patients should seek medical attention if symptoms suggestive of liver dysfunction develop, including jaundice or other significant changes in health.
Cardiovascular and Lipid Effects
The supplied information states that anabolic steroids can increase low-density lipoprotein (LDL) cholesterol and decrease high-density lipoprotein (HDL) cholesterol.
Changes in lipid profiles can be clinically relevant because abnormal cholesterol levels may contribute to cardiovascular risk.
The source also lists hypertension, oedema and other cardiovascular-related effects among possible adverse reactions.
Haematological Effects
The supplied material states that anabolic steroids may suppress clotting factors II, V, VII and X and may increase prothrombin time.
Patients receiving anticoagulants should therefore be appropriately monitored, particularly when anabolic steroid treatment is initiated or discontinued.
The product should not be presented as having no effect on blood coagulation.
Endocrine and Reproductive Effects
Exogenous anabolic-androgenic steroids can suppress endogenous hormonal signalling through negative feedback at the hypothalamic and pituitary levels.
The supplied source identifies:
Oligospermia
Excessive or prolonged erections
Gynecomastia
Inhibition of gonadotropin secretion
as possible effects.
These findings reflect the systemic endocrine activity of anabolic steroids and are important considerations for patients receiving androgen therapy.
Reported Adverse Reactions
The supplied information reports a broad range of possible adverse effects, including:
Gynecomastia
Prolonged or excessive erections
Oligospermia
Acne
Increased body hair
Male-pattern hair loss
Fluid retention
Nausea
Cholestatic jaundice
Abnormal liver-function tests
Changes in serum lipids
Hypertension
Oedema
Headache
Anxiety
Depression
Changes in libido
Reduced glucose tolerance
Sleep-apnoea-related effects
The source also identifies rare serious hepatic complications.
The absence or presence of an individual reaction can vary between patients.
Contraindications
According to the supplied information, methandienone should not be used in patients with:
Known or suspected male breast carcinoma
Known or suspected prostate carcinoma
Certain female breast-carcinoma conditions associated with hypercalcaemia
Nephrosis or the nephrotic phase of nephritis
Hypercalcaemia
Pre-existing cardiac disease
Renal disease
Hepatic disease
Pregnancy or potential pregnancy
The supplied source specifically states that methandienone is not indicated for women, children or elderly patients.
Monitoring
The supplied source recommends monitoring several clinical and laboratory parameters, including:
Serum cholesterol
HDL
LDL
Triglycerides
Haemoglobin
Haematocrit
AST and ALT
Prostate-specific antigen (PSA)
Testosterone
Dihydrotestosterone
Estradiol
It also recommends prostate assessment in men over 40 before androgen therapy and periodic evaluation during treatment.
These monitoring requirements highlight the systemic nature of anabolic-androgenic steroid therapy.
Drug Interactions
The supplied information identifies interactions with oral hypoglycaemic agents and anticoagulants.
Anabolic steroids may affect glucose metabolism and alter sensitivity to oral anticoagulants. Patients taking these medicines require appropriate professional monitoring.
The source recommends careful monitoring during the initiation and termination of anabolic steroid therapy.
Dosage and Administration
The supplied source includes a proposed adult male dosage range of 10–30 mg per day for 3–6 weeks.
Because this is a pharmacologically active prescription steroid and the supplied dose has not been independently verified for the specific commercial product or jurisdiction, it is presented here only as information contained in the source rather than as a recommendation.
Patients should not self-adjust the dose, extend treatment duration or use the product outside the directions of a qualified healthcare professional.
Product Presentation
Methandienone 10 mg uncoated tablets – 100 tablets in one bottle.
Each tablet is stated to contain 10 mg of methandienone.
Manufacturer Information
Company: Hilma Biocare.
No additional GMP, batch-release, certificate-of-analysis or regulatory documentation was supplied.
Regulatory Information
The supplied source identifies the market status as Prescription.
No EU marketing authorisation number or country-specific regulatory approval was supplied for this particular product presentation. Therefore, no claim is made that Methandienone 10 is authorised or legally saleable in every European country.
Applicable regulatory status should be verified with the relevant national medicines authority.
Storage
The supplied storage recommendation is:
Store between 15–25°C and protect from light.
Keep the product according to the manufacturer’s current packaging and official storage instructions.
Important Pharmaceutical Disclaimer
Methandienone (Dianabol) is a pharmacologically active anabolic-androgenic steroid with significant endocrine and hepatic considerations. The bodybuilding-related claims in the source have not been presented as guaranteed outcomes.
This information is based on the supplied product material and does not replace official prescribing information or professional medical advice. It should not be interpreted as a recommendation for non-prescribed use.
